Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 May;48(2):491–498.

Kinetics of specific in vitro antibody production following influenza immunization.

D M Mitchell, P Fitzharris, R A Knight, G C Schild
PMCID: PMC1536451  PMID: 7105493

Abstract

In vitro specific antibody responses to influenza viral antigens by peripheral blood mononuclear leucocytes following stimulation with influenza virus or pokeweed mitogen have been measured before and at time intervals after influenza immunization in 11 healthy volunteers. There was an early increase in specific antibody produced by lymphocytes stimulated with influenza virus in vitro, in all subjects immunized. The magnitude of the response varied considerably between individuals as did its duration. Virus specific antibody production by cells stimulated with pokeweed mitogen also increased after immunization in all donors. Cells from six of the 11 individuals produced specific antibody in vitro seven days after immunization without antigen or mitogen stimulation. Seven of the 11 subjects had a greater than four-fold increase in serum titre of haemagglutination inhibiting antibody. This study shows an early brisk increase in the ability of lymphocytes to respond to influenza virus in vitro following immunization consistent with a secondary immune response.

Full text

PDF
491

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Callard R. E. Specific in vitro antibody response to influenza virus by human blood lymphocytes. Nature. 1979 Dec 13;282(5740):734–736. doi: 10.1038/282734a0. [DOI] [PubMed] [Google Scholar]
  2. Freestone D. S., Hamilton-Smith S., Schild G. C., Buckland R., Chinn S., Tyrrell D. A. Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines. J Hyg (Lond) 1972 Sep;70(3):531–543. doi: 10.1017/s0022172400063117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Geha R. S. Dynamics of human circulating antigen reactive cells following secondary immunization with tetanus toxoid. Clin Immunol Immunopathol. 1981 May;19(2):196–205. doi: 10.1016/0090-1229(81)90063-5. [DOI] [PubMed] [Google Scholar]
  4. Geha R. S., Mudawwar F., Schneeberger E. The specificity of T-cell helper factor in man. J Exp Med. 1977 Jun 1;145(6):1436–1448. doi: 10.1084/jem.145.6.1436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hoskins T. W., Davies J. R., Allchin A., Miller C. L., Pollock T. M. Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. Lancet. 1973 Jul 21;2(7821):116–120. doi: 10.1016/s0140-6736(73)93062-6. [DOI] [PubMed] [Google Scholar]
  6. Kaplan M. E., Clark C. An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods. 1974 Jul;5(2):131–135. doi: 10.1016/0022-1759(74)90003-9. [DOI] [PubMed] [Google Scholar]
  7. Platts-Mills T. A., Ishizaka K. IgA and IgA diphtheria antitoxin responses from human tonsil lymphocytes. J Immunol. 1975 Mar;114(3):1058–1064. [PubMed] [Google Scholar]
  8. Rowley D. A., Gowans J. L., Atkins R. C., Ford W. L., Smith M. E. The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats. J Exp Med. 1972 Sep 1;136(3):499–513. doi: 10.1084/jem.136.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Schulman J. L., Khakpour M., Kilbourne E. D. Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol. 1968 Aug;2(8):778–786. doi: 10.1128/jvi.2.8.778-786.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Slepushkin A. N., Schild G. C., Beare A. S., Chinn S., Tyrrell D. A. Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) 1971 Dec;69(4):571–578. doi: 10.1017/s0022172400021847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stevens R. H., Macy E., Morrow C., Saxon A. Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol. 1979 Jun;122(6):2498–2504. [PubMed] [Google Scholar]
  12. Thomson P. D., Harris N. S. Detection of plaque-forming cells in the peripheral blood of actively immunized humans. J Immunol. 1977 Apr;118(4):1480–1482. [PubMed] [Google Scholar]
  13. Tyrrell D. A., Smith J. W. Vaccination against influenza A. Br Med Bull. 1979 Jan;35(1):77–85. doi: 10.1093/oxfordjournals.bmb.a071546. [DOI] [PubMed] [Google Scholar]
  14. Voller A., Bidwell D. E., Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ. 1976;53(1):55–65. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES